Frontotemporal dementia – reasons for misdiagnosis – University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis of this notoriously difficult to diagnose disorder. Psychiatrist Dr Joshua Flavell, working with cognitive neurologist Professor […]
Read More… from Frontotemporal dementia – reasons for misdiagnosis
‘Bruce Willis effect’ – Die Hard star’s diagnosis sees 2023 web spike in interest in rare dementia. The UK’s leading dementia charity has revealed a surge in people reading up about one of the less common types of dementia this year – the same condition that Bruce Willis was diagnosed with. Alzheimer’s Society has revealed […]
Read More… from Bruce Willis’s diagnosis sees 2023 web spike in interest in rare dementia
Dementia is a public health priority with a huge human and economic burden. 50 million people are living with dementia globally and 850,000 of those are in the UK. As the population grows it is predicted that by 2025 over one million people in the UK may have dementia and by 2050, 152 million people […]
New blood test for the diagnostics of frontotemporal dementia. A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals. Frontotemporal dementia is the second most […]
Read More… from New blood test for the diagnostics of frontotemporal dementia